chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Culture negative, Dyspnoea, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal
Clinical narrative: Patient developed sore arm soreness 10/14/13. Then on 10/17/13 developed muscle pains in lower extremities with intermittent weak feeling. Progressed 10/21 to diffuse muscle pains over entire body. Then 10/25 also having chest tightness and shortness of breath. Was admitted to hospital 10/25 and had LP and MRI. Did not receive steroids or IVIG.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Nuclear magnetic resonance imaging spinal normal, Pain in extremity, Red blood cells CSF positive
Clinical narrative: Patient developed sore arm soreness 10/14/13. Then on 10/17/13 developed muscle pains in lower extremities with intermittent weak feeling. Progressed 10/21 to diffuse muscle pains over entire body. Then 10/25 also having chest tightness and shortness of breath. Was admitted to hospital 10/25 and had LP and MRI. Did not receive steroids or IVIG.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Cheilitis, Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: Top and bottom lips became tingly and numb, tip of tounge became numb, red demarkation noted above upper lip and nose.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Dysgeusia, Nausea, Sinus operation
Clinical narrative: Upon return to work, within 30 minutes had very strong metal taste in mouth. Noticed the sinus drainage also strong taste of metal.  11:00 nauseated, but never threw up.  Ate bland lunch, but 1:00 pm the taste had lessened, but not ceased.  Had mild metal taste for at least three days. The vaccine the health department used was 2013-2014 Fluarix Quadrivalent
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Bronchitis, Neck pain
Clinical narrative: SYNCOPE with upset stomach, neck pain lasting in waives up to 1 hour.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Patient woke with injection site erythemic, edematous, warm, and about an area of 5cm square. No respiratory distress, angioedema, fever, pain with ambulation, or exudate oozing from area.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Vision blurred
Clinical narrative: Woke up day after flu shot with increasingly blurred/worse vision, by noon only able to make out large shapes no print. Seen by optometrist.
Age: 25.0
Sex: M
Vaccine: FLU3
Symptoms: Confusional state, Dyspnoea, Fatigue, Urticaria
Clinical narrative: Hives spread across arm, Shortness of breath increased. Some confusion and fatigue occurred around 10PM.  Went to ER and received Benadryl and Prednisone for presumed allergic reaction.
Age: 58.0
Sex: M
Vaccine: UNK
Symptoms: Erythema, Induration, Pain, Tenderness
Clinical narrative: Pain, induration, erythema, tenderness beginning 1 day after vaccination and continues 5 days later, though improved. Pt was taking azithromycin for other diagnosis during this time.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chills, Cough, Headache, Night sweats
Clinical narrative: Red eyes, tightness of chest, coughing, headache, body aches, chills and sweating during the night.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Pain
Clinical narrative: Red eyes, tightness of chest, coughing, headache, body aches, chills and sweating during the night.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Areflexia, Arthralgia, Asthenia, Ataxia, Balance disorder
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Blood immunoglobulin A normal, Demyelinating polyneuropathy, Differential white blood cell count normal, Electrocardiogram, Fall
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Full blood count normal, Guillain-Barre syndrome, Hypertension, Immunoglobulin therapy, Insomnia
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Joint range of motion decreased, Laboratory test normal, Limb discomfort, Lumbar puncture, Muscular weakness
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Myalgia, Myositis, Nerve conduction studies abnormal, Neurological examination abnormal, Nuclear magnetic resonance imaging spinal normal
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 67.0
Sex: M
Vaccine: FLU4
Symptoms: Pain, Urine analysis normal, Walking aid user, Wheelchair user
Clinical narrative: Patient presents to ED on 10/30/13 with a chief complaint of bilateral lower extremity weakness with muscle and joint pain beginning two days ago upon awakening in the morning. He had been jogging two days prior to symptom onset and experienced only mild soreness the day following running. For the past two days, he has been having trouble balancing and has been requiring a cane for ambulation. He denies fever, chills, shortness of breath, nausea, headache, and dizziness, and he is not currently taking any medications. Recent medical history consists of a colonoscopy on 10/3/13 and an upper respiratory infection five weeks ago, from which he recovered within ten days. The patient also received a flu shot (Fluarix Quadrivalent) on 10/14/13. Pertinent labs/tests (urinalysis, chemistry, CBC with differential, DVT work-up, and lumbar MRI) are performed and determined to be insignificant. The patient is diagnosed with weakness and myositis and is discharged home with Medrol Dosepack prescription. The patient presents back to the ED two days later (11/1/13) with complaints of worsening weakness in calves and reports falling to the floor when trying to squat. He continues to require a cane/walker for support. On neurologic exam, he is ataxic with absent reflexes. An EKG and LP are completed, and the patient is admitted to hospital. Neurology is consulted and reports that the test results are concerning for Guillain Barre Syndrome (GBS).  IgA level is 228, and patient is started on IVIG 35 grams once daily for a total of 5 days, beginning on 11/2/13. Patient also receives IVF, diphenhydramine, prophylactic-dose enoxaparin, acetaminophen, and baclofen. Nerve conduction studies on 11/6/13 are consistent with acute acquired demyelinating neuropathies such as GBS. The patient is followed by physical therapy throughout his stay. Although he is stable, there is little improvement noted after the five IVIG treatments. The patient has also been experiencing new episodes of hypertension (indicating some possible autonomic dysfunction) for which he is given IV beta-blockers. No changes in respiratory function, bowel or bladder function, cognition, or vision are noted. The patient does complain of some difficulty sleeping at night due to leg discomfort.  On 11/6/13, the patient is admitted to the hospital's inpatient rehabilitation facility for physical therapy, occupational therapy, and neuropsychology. He is currently in a wheelchair requiring maximal assistance. His right lower extremity is slightly stronger than his left. Right Knee Exam (RKE) is graded at 3/5 (joint can only be moved against gravity; inability to move against resistance). LKE exam is graded at 1/5 (only a trace or flicker of movement is seen or felt in the muscle). Patient remains in the rehab center as of 11/13/2013.
Age: 2.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Cough, Middle insomnia, Vomiting
Clinical narrative: Woke in the night with coughing that led to vomiting, followed by a temperature reading of 100.4 F rectal.  I am having mother continue to monitor temperature and other sx, thought patient is behaving normally today.
Age: 3.0
Sex: M
Vaccine: FLU4, PNC13
Symptoms: Injury associated with device, Scratch
Clinical narrative: RN administered vaccine in Right Thigh. When RN pulled needle out, pt.'s swiped hand at needle and caused a shallow approx. 1 inch scratch to thigh with needle. RN cleaned the scratch with an alcohol swab and bandaged it.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Eye swelling, Eyelid oedema, Skin discolouration
Clinical narrative: Approx 39 hours after being vaccinated, noted left eye periorbital swelling which proceeded to swelling shut over the next 72 hours and bruise like discoloration to eyelid/periorbital area.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Eyelid oedema, Eyelids pruritus, Lacrimation increased, Urticaria
Clinical narrative: Approx 28 hours after vaccine given, noted right inner eyelid started itching, watering, then started to swell shut after another 2-3 hours. 3 hours later, noted itching and whelps on scalp, back of neck, chest and bil thighs. Took 50mg Benadryl po 1 time at 9pm on 11/12/13. Itching resumed on 11/13/13 at 8:30am. No whelps noted.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: I have experienced pain and redness at the injection site for over a month. The redness has subsided but it is still painful to the touch. I received the intradermal flu shot.
Age: 75.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Nausea, Vertigo
Clinical narrative: Nauseated, dizzy vertigo.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Erythema, Eyelid oedema, Pyrexia, Rash macular
Clinical narrative: Phone call from patients mother to tell health unit that her daughter received flu vaccine at public mass flu clinic on 10/29/13 and started having symptoms on 11/2/13.  Symptoms included facial and eylid swelling, aching joints, red blotchy skin and fever.  Went to her MD and was diagnosed with Upper Respiratory Infection and placed on antibiotics.  MD told her he did not think it was a reaction to the flu shot.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Swelling face, Upper respiratory tract infection
Clinical narrative: Phone call from patients mother to tell health unit that her daughter received flu vaccine at public mass flu clinic on 10/29/13 and started having symptoms on 11/2/13.  Symptoms included facial and eylid swelling, aching joints, red blotchy skin and fever.  Went to her MD and was diagnosed with Upper Respiratory Infection and placed on antibiotics.  MD told her he did not think it was a reaction to the flu shot.
Age: 9.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Injection site swelling
Clinical narrative: Local arm swelling to influenza vaccine given at pharmacy.
Age: 9.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Local swelling
Clinical narrative: Local arm swelling to influenza vaccine given at pharmacy.
Age: 24.0
Sex: F
Vaccine: FLUN4
Symptoms: Exposure during pregnancy, Pregnancy test positive
Clinical narrative: Positive pregnancy test.
Age: 51.0
Sex: F
Vaccine: FLUN4
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Myalgia
Clinical narrative: Began with diarrhea in the morning, progressed by early afternoon to have chills, fatigue.  Progressed by 7 pm to severe chills, fever of 100.9, severe muscular and joint aches, diarrhea.  Relieved minimally by three doses of 400 mg ibuprofen throughout day.  Called Dr on call to see if urgent care center visit was warranted.  Symptoms except extreme fatigue resolved by 11/13/2013 at 2 a.  Noticed right eye blurred vision by 11/13/2013 at 5 pm, with minimal aches, continued fatigue.
Age: 51.0
Sex: F
Vaccine: FLUN4
Symptoms: Pyrexia, Vision blurred
Clinical narrative: Began with diarrhea in the morning, progressed by early afternoon to have chills, fatigue.  Progressed by 7 pm to severe chills, fever of 100.9, severe muscular and joint aches, diarrhea.  Relieved minimally by three doses of 400 mg ibuprofen throughout day.  Called Dr on call to see if urgent care center visit was warranted.  Symptoms except extreme fatigue resolved by 11/13/2013 at 2 a.  Noticed right eye blurred vision by 11/13/2013 at 5 pm, with minimal aches, continued fatigue.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Sore arm, unable to lift above head.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Generalised erythema, Miliaria, Pruritus
Clinical narrative: Sore arm, unable to lift above head.
Age: 0.18
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, RV1
Symptoms: Constipation, Convulsion, Failure to thrive, Gastrointestinal tube insertion, Vomiting
Clinical narrative: Patient visited the hospital after 2 month shots as well as after her 4 month shots. In September shortly after her 4 month shots were given the mother brought in patient. Patient was vomiting and had not had a bowel movement in several days. Baby was sent to hospital and was diagnosed with failure to thrive. Since this that baby has lost weight, not gained very much at all, experienced seizures, had vomiting and constipation. Patient was placed on a feeding tube.
Age: 0.18
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, RV1
Symptoms: Weight decreased, Weight gain poor
Clinical narrative: Patient visited the hospital after 2 month shots as well as after her 4 month shots. In September shortly after her 4 month shots were given the mother brought in patient. Patient was vomiting and had not had a bowel movement in several days. Baby was sent to hospital and was diagnosed with failure to thrive. Since this that baby has lost weight, not gained very much at all, experienced seizures, had vomiting and constipation. Patient was placed on a feeding tube.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: EXTREME DIZZINESS, NAUSEA, AND VOMITING. BEGAN A FEW HOURS AFTERWARDS. SYMTOMS IMPROVED ON THE MORNING OF 11/13/13. PATIENT SELF TREATED.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chills, Cough, Dysphonia, Dyspnoea
Clinical narrative: Starting coughing around 7:15, then chest felt tight and had trouble breathing. Took 2 Benadryl. 3 hours later woke up to extreme nausea. Around 6 am on 11/12/2103 woke up having chills and extreme tiredness and hoarseness with congestion. Generally a healthy person and was completely fine before shot was administered.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Nausea, Respiratory tract congestion
Clinical narrative: Starting coughing around 7:15, then chest felt tight and had trouble breathing. Took 2 Benadryl. 3 hours later woke up to extreme nausea. Around 6 am on 11/12/2103 woke up having chills and extreme tiredness and hoarseness with congestion. Generally a healthy person and was completely fine before shot was administered.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Expired drug administered
Clinical narrative: Expired vaccine given.
Age: 36.0
Sex: F
Vaccine: FLUX
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful swollen gland above left collarbone (superclavicular lymph node?) - felt like a hard sore lump. Stayed very sore for a few days and then pain gradually began to abate and swelling went down. It is 2 weeks later now and it still feels very slightly swollen, but is no longer painful. Did not seek treatment, but I did ask my pharmacist if it was a normal side effect or not. She said it was rare but not entirely unheard of.
Age: 10.0
Sex: M
Vaccine: FLU4
Symptoms: Dizziness, Fall, Head injury
Clinical narrative: Dizziness 15 minutes after vaccination. Fell and hit head on way back to class. No loss of consciousness. Was able to return to class after 30 minute rest in principal office.
Age: 12.0
Sex: M
Vaccine: FLU4
Symptoms: Abdominal discomfort, Vomiting
Clinical narrative: Approximately 30 min after vaccination, client came to school nurse office with severe GI upset. Vomited multiple times over next 30 min. No treatment was given at the school.
Age: 19.0
Sex: M
Vaccine: FLU4
Symptoms: Pharyngeal oedema, Pruritus, Urticaria
Clinical narrative: Patient called reporting hives, itching, swelling in her throat. Time of adverse event was at 1630. Follow-up with patient reporting that care was received at the local hospital and she wasn't not hospitalized but discharged that evening. Patient reported that she was given Claritin at the ER as treatment for her symptoms.
Age: 0.01
Sex: M
Vaccine: HEP
Symptoms: Eczema, Sensory disturbance, Speech disorder developmental
Clinical narrative: My son suffers from horrible eczema on his legs, he has a speech delay, and is also working with an occupational therapist due to low sensory awareness. He is currently working with a speech specialist as well.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Abortion spontaneous, Exposure during pregnancy
Clinical narrative: Miscarriage. Notified of nonviable pregnancy on 10/22/2013. Actual miscarriage on 11/02/2013.
Age: 28.0
Sex: F
Vaccine: FLU4, TD
Symptoms: Arthralgia, Dizziness, Malaise, Nausea, Pain
Clinical narrative: Right after shot, I had pain in the joints of my left hand.  I didn't think much of it as I had received the shot in my left deltoid.  At 2 am the  night, I woke up in severe pain.  Everything hurt.  I was also nauseous.  When I got out of bed at 6am I was having dry heaves and when I stood, darkness closed in around my eyes as though I was going to pass out.  I visited a nurse, who told me to take antihistamines, pushed fluids and advised prolonged rest.  I am still not feeling well and it has been 2 days.
Age: 28.0
Sex: F
Vaccine: FLU4, TD
Symptoms: Retching
Clinical narrative: Right after shot, I had pain in the joints of my left hand.  I didn't think much of it as I had received the shot in my left deltoid.  At 2 am the  night, I woke up in severe pain.  Everything hurt.  I was also nauseous.  When I got out of bed at 6am I was having dry heaves and when I stood, darkness closed in around my eyes as though I was going to pass out.  I visited a nurse, who told me to take antihistamines, pushed fluids and advised prolonged rest.  I am still not feeling well and it has been 2 days.
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: Injection site had a slightly raised area, like a pimple.  Approximately 1 inch away, a swollen ridge about 3 inches long in the bicep.  By the 3rd day after the injection, still has slightly raised area at injection site, but now a red, swollen and hot area about the size of a plum on the bicep. Arm sore to move or touch.
Age: 34.0
Sex: F
Vaccine: HEP, TDAP
Symptoms: Arthralgia, Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient received two immunizations on 11/08/13. A Td in the left deltoid and adult Hep B  in the right deltoid. On the morning of 11/09/13, patient reports having joint pain, then swelling of her arm from elbow to shoulder with redness and warmth. Went to ER on 11/10/13. Diagnosed with cellulitis and given 2 antibiotics and Naproxen.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Pt. reports pain down entire arm for several days, it got better, but  then returned again.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling, Vomiting
Clinical narrative: Site is swollen sore vomiting x 5hrs. according to patient.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Cold sweat, Dizziness, Limb immobilisation, Musculoskeletal chest pain, Musculoskeletal pain
Clinical narrative: No treatment. Severe arm pain in left arm that moved under rib cage and shoulder blade. Paleness. Nausea. Dizziness. Faintness. Skin was clammy. Required immobilization of arm.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Pain in extremity, Pallor
Clinical narrative: No treatment. Severe arm pain in left arm that moved under rib cage and shoulder blade. Paleness. Nausea. Dizziness. Faintness. Skin was clammy. Required immobilization of arm.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Rash
Clinical narrative: Patient had a rash that started this morning. The patient was evaluated by the pediatrician.
Age: 53.0
Sex: M
Vaccine: TDAP
Symptoms: Antinuclear antibody, Full blood count, Hypoaesthesia, Metabolic function test
Clinical narrative: Pt reported generalized numbness in entire body after TDap vaccine, evaluated by neurologist on 8-16-13.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site atrophy, Injection site reaction
Clinical narrative: Muscle atrophy at injection site.
Age: 31.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Headache, Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: Left arm extremely sore. Friday body aches, fever, severe chills, severe HA. Urgent Care Friday. IV fluids. Cannot lift left arm. Woke up Saturday (11-9-13) large rash on left arm, swollen and warm to the touch. Dr started Cefdinir on 11-9-13.
Age: 31.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia, Rash, Skin warm, Swelling
Clinical narrative: Left arm extremely sore. Friday body aches, fever, severe chills, severe HA. Urgent Care Friday. IV fluids. Cannot lift left arm. Woke up Saturday (11-9-13) large rash on left arm, swollen and warm to the touch. Dr started Cefdinir on 11-9-13.
Age: 83.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Musculoskeletal pain, Neck pain, Pain, Rash
Clinical narrative: Pt woke up Saturday 11/9 complained of spot on (L) breast that went away (not colored - just a spot). Top of shoulder ached and back of neck. Pt took 2x TYLENOL Extra strength; felt better; woke up Monday 11/11 aching all over; took additional TYLENOL.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Redness and soreness at site of injection the circle of redness about 1 inch radius around the injection mark. Area feels like a bruise and itches sometimes. It hurt as the injection was given.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 9.0
Sex: F
Vaccine: FLU3
Symptoms: Lacrimation increased, Ocular hyperaemia, Rash, Urticaria
Clinical narrative: Received flu shot via school program. Waited 15 + min. post-vax, returned to class. Returned to flu clinic site about 1 hr later with tender D/T rash/hive around eyes and watery/red eyes; No other symptoms (no difficulty breathing). 911 called, EMS administered BENADRYL and took pt to ER. Per school liaison, symptoms resolved by the time pt. arrived at ER.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis
Clinical narrative: Possible cellulitis treated by MD with CIPRO and triamcinolone cream.
Age: 67.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Local swelling, Night sweats, Pain in extremity
Clinical narrative: Sore arm 5 hours after shot. Next day had swelling of arm from elbow to shoulder and bright pink to red in color. Had extreme night sweat second night after shot. Swelling subsided by Monday (shot given on Thursday). Shoulder to wrist very sensitive for about 4 days. No treatment.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Lip swelling
Clinical narrative: Patient reported swelling at lips at 4:30 PM. Patient took Benadryl 50mg at that time. At 6:30 PM patient reported swelling going down. On 11-13-13 patient report all symptoms were gone.
Age: 18.0
Sex: M
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site induration
Clinical narrative: Injected flu vaccine to right deltoid, checked for blood return, seen none, vaccine given then immediately observed an induration (topical) and slight redness. Dr. notified. Ice apply and BENADRYL 50mg given via G tube. V/S as follow BP 130/97 HR: 111, RR 21, and O2 sat 94% on room air, no respiratory distress noted, at this time. After 30 minutes no redness, no swelling, and no respiratory distress, and no rashes noted, at this time.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: Rashing from flu shot itching, started after.
Age: 74.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site mass, Injection site pain, Pain in extremity
Clinical narrative: Lump and pain at injection site. Pain radiating down arm.
Age: 74.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site pain, X-ray limb normal
Clinical narrative: Lump and pain at injection site. Pain radiating down arm.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: Redness, swelling of site of vaccine administration - compress, MOTRIN and BENADRYL PRN as directed. Dosage confirmed with parent.
Age: 18.0
Sex: M
Vaccine: FLU4, HPV4
Symptoms: Dizziness
Clinical narrative: Pt felt dizzy after 2nd HPV. Layed pt down 10 minutes pt felt better and was discharged.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Pyrexia, Vomiting
Clinical narrative: Pt received HIGH DOSE flu within 8 hrs had fever of 101 degrees and was vomiting. Has resolved pt feels "weak".
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: Information was received from an immunization program of a community nursing service concerning a patient (demographics not provided). On an unknown date, the patient was vaccinated with GARDASIL, lot # J003727 (exp. 07-NOV-2015) (dosage and route of administration not provided). The vaccine was reported to have been improperly stored. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Injection site vesicles, Pyrexia
Clinical narrative: Information has been received from a pharmacist via sales representative regarding a 68 year old female patient. The patient's medical history, drug reaction and allergies were not provided. On 22-OCT-2013, the patient was vaccinated with a subcutaneous dose of ZOSTAVAX, single stand dose, (dose and lot number were not provided). On 22-OCT-2013, the patient developed a blister at the injection site after received ZOSTAVAX accompanied by fever and chills. The patient sought medical attention, at office visit. At the time of the report, the patient had not recovered from the adverse event. Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Information was received from a healthcare worker regarding a female patient. On an unknown date, at age 26 years and 4 months, the patient was vaccinated with her first dose of GARDASIL (dosage and route of administration not provided). She received the second dose of GARDASIL at 27 years old. No adverse effects reported. Additional information has been requested.
Age: 1.03
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 12 month old female patient. Medical history and drug reactions/allergies were not reported. On 06-NOV-2013 the patient was vaccinated with VARIVAX lot # H016759 exp date 10-SEP-2014, 0.5 ml, subcutaneous and PROQUAD lot # H021362 exp date 29-MAY-2014, 0.5 ml, subcutaneous. Concomitant medication was not reported. The patient was observed at the office for approximately one half hour. No adverse effect reported. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous report as received from a pharmacist via a company representative refers to a 66 year old male patient. Medical history and drug allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (concentration, dose, frequency and lot number were not reported). No concomitant therapy was reported. On an unknown date, the patient experienced unusually large injection site rashes 10 days after receiving ZOSTAVAX. The ras was extremely swollen, hot and red. The patient did not sought medical attention. The outcome of the event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Secondary transmission
Clinical narrative: Information was received from a pharmacist. In 2012, a patient received ZOSTAVAX. It was reported that an immediate family member developed shingles about one or two weeks later. No further information was received. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history and drug allergies were not reported. Since 31-OCT-2013, the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular (lot number and concentration were not reported) that had been improperly stored. No adverse effects were reported. Additional information has been requested.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Feeling abnormal, Injection site discomfort, Injection site erythema, Injection site warmth, Rash
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 57 year old male patient. The patient had no drug reactions or allergies. on 30-OCT-2013 the patient was vaccinated with ZOSTAVAX (subcutaneous in the left arm, 0.65 ml, lot # J006828 EXP 14-SEP-2014) for prevention of shingles. Concomitant therapies included "flu shot" (manufacturer unknown) (received on 23-OCT-2013). On 30-OCT-2013, the patient experienced redness, about "fist size", on the left posterior bicep, around injection site, which was warm to touch and uncomfortable. On 31-OCT-2013 the patient was treated with BENADRYL orally and used BENADRYL cream topically. Pharmacist reported that on 11-NOV-2013 the patient experienced "doesn't feel like he normally would". Pharmacist reported redness was varying degrees of red, which could be a rash. Patient was sent to see his physician on 01-NOV-2013. Pharmacist accepted VZVIP packet and VZVIP packet was faxed. The patient sought medical attention (saw a pharmacist) and received treatment. The outcome of the events was unknown. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Exposure during pregnancy, Human chorionic gonadotropin positive, No adverse event
Clinical narrative: This spontaneous prospective pregnancy report was received from a registered nurse refers to a 26 years old female patient. The patient's medical history included cervical dysplasia. No known allergies. The patient's history of previous pregnancies and live births was not known. Prior to vaccination (on 26-JUL-2012) a urine pregnancy test was performed which resulted negative. On 26-JUL-2012, the patient was vaccinated with first dose, 0.5 milliliter (ml) GARDASIL (lot number 0417AE, expiration date was 29-SEP-2014) intramuscularly (im) into the left arm (reported as left deltoid). No concomitant medications were taken by the patient. The patient was seen in the office on 16-AUG-2012 and a quantitative human chorionic gonadotropin (HCG) blood test was positive. Subsequently, the patient became pregnant with last menstrual period (LMP) of 23-JUN-2012 and the estimated date of delivery (EDD) was 30-MAR-13. The patient was exposed to GARDASIL during trimester 1. The patient was not experiencing any adverse effects. Pregnancy outcome was pending. Follow up information received. EDD was reported as April 2013 (previously estimated as 30-MAR-2013 according to the LMP). Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 65 year old female patient with no medical history or allergies. On 15-SEP-2011, the patient was vaccinated with a dose of ZOSTAVAX (unspecified Lot # and expiration date, dose, frequency and route not reported) and then received another dose of ZOSTAVAX (lot # reported as 0236AE and unspecified expiration date, dose, frequency and route not reported) on 05-OCT-2012. There was no concomitant medication. Approximately in October 2012, a "couple of days after" received the ZOSTAVAX, on 05-OCT-2012, the patient developed shingles. The patient sought an unspecified physician on an unspecified date regarding the reaction. The outcome of shingles was recovered. Additional information is not expected.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy report as received from a registered nurse refers to a 33 year old female patient. Pertinent medical history, drug reactions or allergies were not reported. On 11-SEP-2013, the patient was vaccinated with M-M-R II, dose 1, lot # J003791, expiration date: 28-MAR-2015, 0.5 ml, subcutaneous, reason for therapy: non-immune to rubella. Other suspect therapies included AFLURIA (dose, route and lot number were not reported). Concomitant medication was not reported. On 01-OCT-2013, the patient reported for dose of AFLURIA and second dose of M-M-R II. After AFLURIA was administered, the patient stated she may had been pregnant and may had been approximately 3 weeks pregnant at the time of initial M-M-R II on 11-SEP-2013. The patient became pregnant with LMP of 21-AUG-2013 and EDD of 28-MAY-2014. To date, the patient had not received second dose of M-M-R II, nor had she gone to her doctor to confirm suspected pregnancy. It was reported that no treatment was given. The outcome of the event was unknown. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history and drug allergies were not reported. Since 31-OCT-2013, the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular (lot number and concentration were not reported) that had been improperly stored. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect storage of drug
Clinical narrative: This spontaneous report as received from an immunization program refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of improperly stored PNEUMOVAX23 (lot # J006921, expiration date: 09-AUG-2014 (dose and route not reported. Additional information is not expected.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history and drug allergies were not reported. Since 31-OCT-2013, the patient was vaccinated with GARDASIL, 0.5 ml, intramuscular (lot number and concentration were not reported) that had been improperly stored. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.